Genetic Signatures (ASX:GSS) Gross Margin % : 29.44% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Genetic Signatures's Gross Profit for the six months ended in Dec. 2023 was A$1.06 Mil. Genetic Signatures's Revenue for the six months ended in Dec. 2023 was A$3.60 Mil. Therefore, Genetic Signatures's Gross Margin % for the quarter that ended in Dec. 2023 was 29.44%.

The historical rank and industry rank for Genetic Signatures's Gross Margin % or its related term are showing as below:

ASX:GSS' s Gross Margin % Range Over the Past 10 Years
Min: 58.35 Med: 65.34 Max: 74.68
Current: 58.35

During the past 9 years, the highest Gross Margin % of Genetic Signatures was 74.68%. The lowest was 58.35%. And the median was 65.34%.

ASX:GSS's Gross Margin % is ranked better than
62.09% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 46.71 vs ASX:GSS: 58.35

Genetic Signatures had a gross margin of 29.44% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Genetic Signatures was -0.20% per year.

Genetic Signatures Gross Margin % Historical Data

The historical data trend for Genetic Signatures's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Gross Margin % Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Gross Margin %

Get a 7-Day Free Trial

65.35

61.78

65.34

66.15

62.57

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial													68.45	62.46	56.99	67.86	29.44

Competitive Comparison of Genetic Signatures's Gross Margin %

For the Diagnostics & Research subindustry, Genetic Signatures's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Gross Margin % falls into.

Genetic Signatures Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Genetic Signatures's Gross Margin for the fiscal year that ended in Jun. 2023 is calculated as

Gross Margin % (A: Jun. 2023 )	=	Gross Profit (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	13.4	/	21.36
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(21.36 - 7.996)	/	21.36
	=	62.57 %

Genetic Signatures's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1.1	/	3.604
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(3.604 - 2.543)	/	3.604
	=	29.44 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Genetic Signatures (ASX:GSS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Genetic Signatures had a gross margin of 29.44% for the quarter that ended in Dec. 2023 => Competition eroding margins

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Genetic Signatures Gross Margin % Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.